Utilizing MD as a pivotal technique in computer-aided drug discovery, first, the binding efficacy of 128 ginsenosides against SLC3A2 was evaluated, as this protein is highly and consecutively expressed in all cancers (Figure 2B). This evidence concerns the gene SLC3A2 and cancer.